CN114938856A - Natural composite powder for removing helicobacter pylori in vivo and preparation method thereof - Google Patents
Natural composite powder for removing helicobacter pylori in vivo and preparation method thereof Download PDFInfo
- Publication number
- CN114938856A CN114938856A CN202210465121.8A CN202210465121A CN114938856A CN 114938856 A CN114938856 A CN 114938856A CN 202210465121 A CN202210465121 A CN 202210465121A CN 114938856 A CN114938856 A CN 114938856A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- powder
- helicobacter pylori
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000843 powder Substances 0.000 title claims abstract description 133
- 241000590002 Helicobacter pylori Species 0.000 title claims abstract description 65
- 229940037467 helicobacter pylori Drugs 0.000 title claims abstract description 63
- 239000002131 composite material Substances 0.000 title claims abstract description 53
- 238000001727 in vivo Methods 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 63
- 240000000588 Hericium erinaceus Species 0.000 claims abstract description 29
- 235000007328 Hericium erinaceus Nutrition 0.000 claims abstract description 29
- 241000283690 Bos taurus Species 0.000 claims abstract description 28
- 240000001717 Vaccinium macrocarpon Species 0.000 claims abstract description 28
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims abstract description 28
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims abstract description 28
- 210000003022 colostrum Anatomy 0.000 claims abstract description 28
- 235000021277 colostrum Nutrition 0.000 claims abstract description 28
- 235000004634 cranberry Nutrition 0.000 claims abstract description 28
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 28
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 25
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 25
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 25
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 24
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 24
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 20
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 20
- 240000007594 Oryza sativa Species 0.000 claims abstract description 20
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 20
- 244000197580 Poria cocos Species 0.000 claims abstract description 20
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 20
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 20
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 20
- 239000001702 nutmeg Substances 0.000 claims abstract description 20
- 235000009566 rice Nutrition 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 19
- 229920002472 Starch Polymers 0.000 claims abstract description 18
- 235000013312 flour Nutrition 0.000 claims abstract description 18
- 235000019698 starch Nutrition 0.000 claims abstract description 18
- 239000008107 starch Substances 0.000 claims abstract description 18
- 240000006927 Foeniculum vulgare Species 0.000 claims abstract description 17
- 235000009421 Myristica fragrans Nutrition 0.000 claims abstract description 17
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 17
- 235000008397 ginger Nutrition 0.000 claims abstract description 17
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims abstract description 14
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 13
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 13
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 12
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 12
- 244000273928 Zingiber officinale Species 0.000 claims abstract 6
- 238000000605 extraction Methods 0.000 claims description 76
- 239000000126 substance Substances 0.000 claims description 30
- 239000012528 membrane Substances 0.000 claims description 28
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 claims description 27
- XCGZWJIXHMSSQC-UHFFFAOYSA-N dihydroquercetin Natural products OC1=CC2OC(=C(O)C(=O)C2C(O)=C1)c1ccc(O)c(O)c1 XCGZWJIXHMSSQC-UHFFFAOYSA-N 0.000 claims description 27
- 229920001202 Inulin Polymers 0.000 claims description 26
- 102000010445 Lactoferrin Human genes 0.000 claims description 26
- 108010063045 Lactoferrin Proteins 0.000 claims description 26
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 26
- 229940029339 inulin Drugs 0.000 claims description 26
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 26
- 229940078795 lactoferrin Drugs 0.000 claims description 26
- 235000021242 lactoferrin Nutrition 0.000 claims description 26
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 claims description 24
- 229920000189 Arabinogalactan Polymers 0.000 claims description 24
- 239000001904 Arabinogalactan Substances 0.000 claims description 24
- 235000019312 arabinogalactan Nutrition 0.000 claims description 24
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 23
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 23
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 23
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 23
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 23
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 20
- 241000498779 Myristica Species 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000004108 freeze drying Methods 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 9
- 230000007480 spreading Effects 0.000 claims description 8
- 238000003892 spreading Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 4
- 241000675108 Citrus tangerina Species 0.000 claims description 3
- 235000002176 Foeniculum vulgare var vulgare Nutrition 0.000 claims description 3
- 235000020230 cinnamon extract Nutrition 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 229940072117 fennel extract Drugs 0.000 claims description 3
- 229940002508 ginger extract Drugs 0.000 claims description 3
- 235000020708 ginger extract Nutrition 0.000 claims description 3
- 229940098295 nutmeg extract Drugs 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims 2
- 238000007873 sieving Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 230000006870 function Effects 0.000 abstract description 9
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 235000017803 cinnamon Nutrition 0.000 abstract description 2
- 244000270834 Myristica fragrans Species 0.000 abstract 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 229920002307 Dextran Polymers 0.000 abstract 1
- 230000006378 damage Effects 0.000 description 25
- 210000004379 membrane Anatomy 0.000 description 20
- 210000001156 gastric mucosa Anatomy 0.000 description 14
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- 241000234314 Zingiber Species 0.000 description 11
- 230000000975 bioactive effect Effects 0.000 description 11
- 208000014674 injury Diseases 0.000 description 11
- 230000008569 process Effects 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 108700005750 Helicobacter pylori HomB Proteins 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 150000004676 glycans Chemical class 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 208000007107 Stomach Ulcer Diseases 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 235000013406 prebiotics Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 201000005917 gastric ulcer Diseases 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 241000186000 Bifidobacterium Species 0.000 description 4
- 241000589989 Helicobacter Species 0.000 description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000000718 duodenal ulcer Diseases 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 206010017758 gastric cancer Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000015788 innate immune response Effects 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 201000011549 stomach cancer Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010019375 Helicobacter infections Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000010000 Agranulocytosis Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 206010018687 Granulocytopenia Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 208000032140 Sleepiness Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 230000009692 acute damage Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001471 micro-filtration Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000001728 nano-filtration Methods 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- 241000218652 Larix Species 0.000 description 1
- 235000005590 Larix decidua Nutrition 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 125000000089 arabinosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)CO1)* 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000005770 birds nest Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 201000011587 gastric lymphoma Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 108010090785 inulinase Proteins 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000004678 mucosal integrity Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 229940064192 sucralfate oral suspension Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000005765 wild carrot Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to natural composite powder for removing helicobacter pylori in vivo and a preparation method thereof, wherein the preparation method of the natural composite powder for removing helicobacter pylori in vivo comprises the following steps: preparing mixed traditional Chinese medicine extract of clove, hericium erinaceus, poria cocos, kudzu root, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried orange peel and ginger; mixing the powder with fructo-oligosaccharide, yeast beta-dextran, cranberry fruit powder, and bovine colostrum powder to obtain natural composite powder for removing helicobacter pylori in vivo. The invention relates to natural composite powder for removing helicobacter pylori in vivo, which comprises the following components: fructo-oligosaccharide, yeast beta-glucan, cranberry fruit powder, bovine colostrum powder and the rest of mixed traditional Chinese medicines in parts by weight, wherein the mixed traditional Chinese medicines comprise clove, hericium erinaceus, poria cocos, radix puerariae, lotus root starch, glutinous rice flour, cinnamon, fennel, nutmeg, dried orange peel and ginger. The technical scheme of the invention achieves the ideal aims of eliminating helicobacter pylori, reducing the generation of side effects and realizing the supplement of nutritional functions to the maximum extent.
Description
Technical Field
The invention relates to a health food, in particular to natural composite powder for removing helicobacter pylori in vivo and a preparation method thereof.
Background
In 1982, H.pylori (Hp) was discovered by Australian scholarly. Hp colonizes under and between the gastric and gastric mucosal epithelium, invades mucosal epithelial cells, destroys mucosal integrity, and produces various toxic substances, leading to inflammatory necrosis of cells. The diseases associated with helicobacter pylori include chronic gastritis, gastric ulcer, duodenal ulcer, gastric lymphoma, gastric cancer, etc. It has been found that about 60% to 80% of patients with gastric ulcers and more than 95% of patients with duodenal bulbar ulcers are associated with infection by helicobacter pylori at the same time. If the patients with peptic ulcer do not completely eradicate helicobacter pylori, the ulcer can repeatedly attack, and obstruction, perforation, bleeding and even cancerization can be caused after a long time. Hp has been identified by the world health organization as a class I carcinogen, clearly indicating that Hp is an important cause of gastric cancer. In addition, Hp may cause other diseases such as cardiovascular disease, anemia, and idiopathic thrombocytopenic purpura. The international world health organization has identified helicobacter pylori as the first cause of gastric cancer. The existing method for removing helicobacter pylori mostly adopts a quadruple therapy (namely, the combined use of four antibiotics), which not only can cause allergic reactions such as rash and urticaria, but also can cause gastrointestinal reactions such as gastrectasia, stomachache or dyspepsia and inappetence, and also can cause symptoms of nerve functions such as dizziness, headache, nausea or somnolence. And also can cause blood liquid diseases, such as granulocytopenia, and cannot achieve the effects of safely, comprehensively and effectively removing helicobacter pylori and repairing gastric mucosa. According to statistics, the Hp infection rate of China is about 40-70%, which is higher than that of developed countries, the detection rate of Hp in stomach disease patients is far higher than that of common people, about 80-90%, and a pure natural product for safely removing helicobacter pylori brings more health and safety to people.
Disclosure of Invention
The invention aims to provide natural composite powder for removing helicobacter pylori in vivo and a preparation method thereof.
The preparation method of the natural composite powder for removing helicobacter pylori in vivo comprises the following steps:
A. preparing clove, hericium erinaceus, poria cocos, kudzu vine root, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried orange peel, ginger, arabinogalactan, fructooligosaccharide, isomaltooligosaccharide, yeast beta-glucan, epigallocatechin gallate, cranberry fruit powder, bovine colostrum powder, lactoferrin, lactobacillus reuteri and dihydroquercetin;
B. preparing the mixed traditional Chinese medicine extract of clove, hericium erinaceus, poria cocos, radix puerariae, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried orange peel and ginger in equal parts by weight;
C. b, concentrating the traditional Chinese medicine extracting solution obtained in the step B;
D. c, spreading the traditional Chinese medicine extracting solution obtained in the step C into a freeze-drying chamber at the temperature of-80 ℃ for low-temperature drying;
E. d, crushing the dried substance obtained in the step D, and filtering the crushed substance through a 120-mesh sieve to obtain powder;
F. and E, mixing 1 weight part of fructo-oligosaccharide, 0.8-1.2 weight parts of yeast beta-glucan, 0.8-1.2 weight parts of cranberry fruit powder, 0.8-1.2 weight parts of bovine colostrum powder, 0.8-1.2 weight parts of lactoferrin, 0.8-1.2 weight parts of inulin, 0.8-1.2 weight parts of isomaltooligosaccharide, 0.8-1.2 weight parts of arabinogalactan, 0.08-0.12 weight parts of dihydroquercetin, 0.08-0.12 weight parts of lactobacillus reuteri and 0.08-0.12 weight parts of epigallocatechin gallate to obtain the natural composite powder for removing helicobacter pylori in vivo.
The invention discloses a preparation method of natural composite powder for removing helicobacter pylori in vivo, wherein the step B comprises the following steps: selecting equal parts by weight of moldy and rotten-free, worm-eaten-free and dried clove, hericium erinaceus, poria cocos, radix puerariae, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried tangerine peel and dried ginger, cleaning and crushing, mixing crushed mixed materials 0.8-1.2 parts by weight with 18-22 parts by weight of water, putting the mixed materials into an extraction bottle, putting the extraction bottle into a normal-temperature ultrahigh-pressure extractor, carrying out normal-temperature ultrahigh-pressure extraction at a constant pressure of 580MPa-620MPa for 8-40 min/time, pouring out traditional Chinese medicine extracting solution from the extraction bottle, adding 18-22 parts by weight of water into the extraction bottle again, mixing, putting the extraction bottle into the normal-temperature ultrahigh-pressure extractor, carrying out normal-temperature ultrahigh-pressure extraction at a constant pressure of 580MPa-620MPa for 8-40 min/time, taking out the extraction bottle, pouring out the traditional Chinese medicine extracting solution from the extraction bottle, repeating the extraction for 2-6 times, and filtering to obtain Chinese medicinal extractive solution.
The invention discloses a preparation method of natural composite powder for removing helicobacter pylori in vivo, wherein the step C comprises the following steps: and D, selecting membrane packages with different molecular weights of 20-500nm from the traditional Chinese medicine extracting solution obtained in the step B, and concentrating by using a graded vibration membrane.
The preparation method of the natural composite powder for removing helicobacter pylori in vivo comprises the step C of selecting the traditional Chinese medicine extracting solution obtained in the step B from membranes with different molecular weights of 20-100nm, 100-300nm and 450-500nm and concentrating by using a graded vibrating membrane.
The invention discloses a preparation method of natural composite powder for removing helicobacter pylori in vivo, wherein step D is to flatly spread 19-21 parts by weight of traditional Chinese medicine extracting solution obtained in step C into a freeze-drying chamber at the temperature of-80 ℃ for low-temperature drying.
The preparation method of the natural composite powder for removing helicobacter pylori in vivo comprises the step E of collecting the dried substance obtained in the step D, putting the dried substance into a convection crusher, crushing by adopting 4000-9000 convection, and filtering by a 120-mesh sieve to obtain powder.
The preparation method of the natural composite powder for removing helicobacter pylori in vivo comprises the step F of mixing 1 part by weight of the powder obtained in the step E, 0.9-1.1 part by weight of fructo-oligosaccharide, 0.9-1.1 part by weight of yeast beta-glucan, 0.9-1.1 part by weight of cranberry fruit powder, 0.9-1.1 part by weight of bovine colostrum powder, 0.9-1.1 part by weight of lactoferrin, 0.9-1.1 part by weight of inulin, 0.9-1.1 part by weight of isomaltooligosaccharide, 0.9-1.1 part by weight of arabinogalactan, 0.09-0.11 part by weight of dihydroquercetin, 0.09-0.11 part by weight of lactobacillus reuteri and 0.09-0.11 part by weight of epigallocatechin gallate, so as to obtain the natural composite powder for removing helicobacter pylori in vivo.
The invention relates to natural composite powder for removing helicobacter pylori in vivo, which comprises the following components: 0.8-1.2 parts of fructo-oligosaccharide, 0.8-1.2 parts of yeast beta-glucan, 0.8-1.2 parts of cranberry fruit powder, 0.8-1.2 parts of bovine colostrum powder, 0.8-1.2 parts of lactoferrin, 0.8-1.2 parts of inulin, 0.8-1.2 parts of isomaltooligosaccharide, 0.8-1.2 parts of arabinogalactan, 0.08-0.12 parts of dihydroquercetin, 0.08-0.12 parts of lactobacillus reuteri, 0.08-0.12 parts of epigallocatechin gallate and 1 part of mixed traditional Chinese medicine by weight, wherein the mixed traditional Chinese medicine comprises clove, hericium erinaceus, poria cocos, kudzu root, lotus root starch, sticky rice powder, common fennel, nutmeg, dried orange peel and ginger in equal parts by weight.
The invention relates to natural composite powder for removing helicobacter pylori in vivo, which comprises the following components: 0.9-1.1 weight parts of fructo-oligosaccharide, 0.9-1.1 weight parts of yeast beta-glucan, 0.9-1.1 weight parts of cranberry fruit powder, 0.9-1.1 weight parts of bovine colostrum powder, 0.9-1.1 weight parts of lactoferrin, 0.9-1.1 weight parts of inulin, 0.9-1.1 weight parts of isomaltooligosaccharide, 0.9-1.1 weight parts of arabinogalactan, 0.09-0.11 weight parts of dihydroquercetin, 0.09-0.11 weight parts of lactobacillus reuteri, 0.09-0.11 weight parts of epigallocatechin gallate and 1 weight part of mixed traditional Chinese medicine, wherein the mixed traditional Chinese medicine comprises clove extract, hericium erinaceum extract, poria cocos extract, kudzu root extract, lotus root powder extract, glutinous rice flour extract, cinnamon extract, fennel extract, myristica nutmeg extract, dried orange peel extract and the same weight parts of mixed traditional Chinese medicine, Ginger extract.
The invention relates to natural composite powder for removing helicobacter pylori in vivo, which comprises the following components: 1.0 part by weight of fructo-oligosaccharide, 1.0 part by weight of yeast beta-glucan, 1.0 part by weight of cranberry fruit powder, 1.0 part by weight of bovine colostrum powder, 1.0 part by weight of lactoferrin, 1.0 part by weight of inulin, 1.0 part by weight of isomaltooligosaccharide, 1.0 part by weight of arabinogalactan, 0.1 part by weight of dihydroquercetin, 0.1 part by weight of lactobacillus reuteri, and 0.1 part by weight of epigallocatechin gallate.
The technical scheme of the invention is that rare plants are used as raw materials, various natural bioactive substances are extracted by processes of normal-temperature ultrahigh-pressure extraction, molecular vibration membrane concentration, ultralow-temperature freeze-drying, low-temperature convection crushing and the like, and the natural bioactive substances are compounded and processed into the health-care food. The technical scheme of the invention follows the concept of taking food as medicine and taking food as main, and the ideal aims of eliminating helicobacter pylori, reducing the generation of side effects and realizing nutritional function supplement are achieved to the maximum extent.
The technical scheme of the invention utilizes the spicy plants to extract the functional components to eliminate the helicobacter pylori infection source; the cranberry fruit powder, the hericium erinaceus, the bovine colostrum powder and the lactoferrin are added to block the helicobacter pylori Homb protein, the helicobacter pylori Homb protein is wrapped and taken out of a body, and the propagation path is cut off; the nonspecific immune response capability of organisms is improved through the plant polysaccharide, the prebiotics and the dihydroquercetin, and susceptible people are protected, so that the helicobacter pylori is completely eradicated.
Detailed Description
The preparation method of the natural composite powder for removing helicobacter pylori in vivo comprises the following steps:
A. preparing clove, hericium erinaceus, poria cocos, kudzu vine root, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried orange peel, ginger, arabinogalactan, fructo-oligosaccharide, isomalto-oligosaccharide, yeast beta-glucan, epigallocatechin gallate, cranberry fruit powder, bovine colostrum powder, lactoferrin, lactobacillus reuteri and dihydroquercetin;
B. preparing the mixed traditional Chinese medicine extract of clove, hericium erinaceus, poria cocos, radix puerariae, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried orange peel and ginger in equal parts by weight;
C. b, concentrating the traditional Chinese medicine extracting solution obtained in the step B;
D. c, spreading the traditional Chinese medicine extracting solution obtained in the step C into a freeze-drying chamber at the temperature of-80 ℃ for low-temperature drying;
E. d, crushing the dried substance obtained in the step D, and filtering the crushed substance through a 120-mesh sieve to obtain powder;
F. and E, mixing 1 weight part of fructo-oligosaccharide, 0.8-1.2 weight parts of yeast beta-glucan, 0.8-1.2 weight parts of cranberry fruit powder, 0.8-1.2 weight parts of bovine colostrum powder, 0.8-1.2 weight parts of lactoferrin, 0.8-1.2 weight parts of inulin, 0.8-1.2 weight parts of isomaltooligosaccharide, 0.8-1.2 weight parts of arabinogalactan, 0.08-0.12 weight parts of dihydroquercetin, 0.08-0.12 weight parts of lactobacillus reuteri and 0.08-0.12 weight parts of epigallocatechin gallate to obtain the natural composite powder for removing helicobacter pylori in vivo.
The invention discloses a preparation method of natural composite powder for removing helicobacter pylori in vivo, wherein the step B comprises the following steps: selecting equal parts by weight of moldy and rotten-free, worm-eaten-free and dried clove, hericium erinaceus, poria cocos, radix puerariae, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried tangerine peel and dried ginger, cleaning and crushing, mixing crushed mixed materials 0.8-1.2 parts by weight with 18-22 parts by weight of water, putting the mixed materials into an extraction bottle, putting the extraction bottle into a normal-temperature ultrahigh-pressure extractor, carrying out normal-temperature ultrahigh-pressure extraction at a constant pressure of 580MPa-620MPa for 8-40 min/time, pouring out traditional Chinese medicine extracting solution from the extraction bottle, adding 18-22 parts by weight of water into the extraction bottle again, mixing, putting the extraction bottle into the normal-temperature ultrahigh-pressure extractor, carrying out normal-temperature ultrahigh-pressure extraction at a constant pressure of 580MPa-620MPa for 8-40 min/time, taking out the extraction bottle, pouring out the traditional Chinese medicine extracting solution from the extraction bottle, repeating the extraction for 2-6 times, and filtering to obtain Chinese medicinal extractive solution.
The invention discloses a preparation method of natural composite powder for removing helicobacter pylori in vivo, wherein the step C comprises the following steps: and D, selecting membrane packages with different molecular weights of 20-500nm from the traditional Chinese medicine extracting solution obtained in the step B, and concentrating by using a graded vibration membrane.
The preparation method of the natural composite powder for removing helicobacter pylori in vivo comprises the step C of selecting the traditional Chinese medicine extracting solution obtained in the step B from membranes with different molecular weights of 20-100nm, 100-300nm and 450-500nm and concentrating by using a graded vibrating membrane.
The preparation method of the natural composite powder for removing helicobacter pylori in vivo comprises the step D of flatly spreading 19-21 parts by weight of the traditional Chinese medicine extracting solution obtained in the step C into a freeze-drying chamber with the temperature of-80 ℃ for low-temperature drying.
The preparation method of the natural composite powder for removing helicobacter pylori in vivo comprises the step E of collecting the dried substance obtained in the step D, putting the dried substance into a convection crusher, crushing by adopting 4000-9000 convection, and filtering by a 120-mesh sieve to obtain powder.
The preparation method of the natural composite powder for removing helicobacter pylori in vivo comprises the step F of mixing 1 part by weight of the powder obtained in the step E, 0.9-1.1 part by weight of fructo-oligosaccharide, 0.9-1.1 part by weight of yeast beta-glucan, 0.9-1.1 part by weight of cranberry fruit powder, 0.9-1.1 part by weight of bovine colostrum powder, 0.9-1.1 part by weight of lactoferrin, 0.9-1.1 part by weight of inulin, 0.9-1.1 part by weight of isomaltooligosaccharide, 0.9-1.1 part by weight of arabinogalactan, 0.09-0.11 part by weight of dihydroquercetin, 0.09-0.11 part by weight of lactobacillus reuteri and 0.09-0.11 part by weight of epigallocatechin gallate, so as to obtain the natural composite powder for removing helicobacter pylori in vivo.
The invention relates to natural composite powder for removing helicobacter pylori in vivo, which comprises the following components: 0.8-1.2 parts of fructo-oligosaccharide, 0.8-1.2 parts of yeast beta-glucan, 0.8-1.2 parts of cranberry fruit powder, 0.8-1.2 parts of bovine colostrum powder, 0.8-1.2 parts of lactoferrin, 0.8-1.2 parts of inulin, 0.8-1.2 parts of isomaltooligosaccharide, 0.8-1.2 parts of arabinogalactan, 0.08-0.12 parts of dihydroquercetin, 0.08-0.12 parts of lactobacillus reuteri, 0.08-0.12 parts of epigallocatechin gallate and 1 part of mixed traditional Chinese medicine by weight, wherein the mixed traditional Chinese medicine comprises clove, hericium erinaceus, poria cocos, kudzu root, lotus root starch, sticky rice powder, common fennel, nutmeg, dried orange peel and ginger in equal parts by weight.
The invention relates to natural composite powder for removing helicobacter pylori in vivo, which comprises the following components: 0.9-1.1 weight parts of fructo-oligosaccharide, 0.9-1.1 weight parts of yeast beta-glucan, 0.9-1.1 weight parts of cranberry fruit powder, 0.9-1.1 weight parts of bovine colostrum powder, 0.9-1.1 weight parts of lactoferrin, 0.9-1.1 weight parts of inulin, 0.9-1.1 weight parts of isomaltooligosaccharide, 0.9-1.1 weight parts of arabinogalactan, 0.09-0.11 weight parts of dihydroquercetin, 0.09-0.11 weight parts of lactobacillus reuteri, 0.09-0.11 weight parts of epigallocatechin gallate and 1 weight part of mixed traditional Chinese medicine, wherein the mixed traditional Chinese medicine comprises clove extract, hericium erinaceum extract, poria cocos extract, kudzu root extract, lotus root powder extract, glutinous rice flour extract, cinnamon extract, fennel extract, myristica nutmeg extract, dried orange peel extract and the same weight parts of mixed traditional Chinese medicine, Ginger extract.
The invention relates to natural composite powder for removing helicobacter pylori in vivo, which comprises the following components: 1.0 part by weight of fructo-oligosaccharide, 1.0 part by weight of yeast beta-glucan, 1.0 part by weight of cranberry fruit powder, 1.0 part by weight of bovine colostrum powder, 1.0 part by weight of lactoferrin, 1.0 part by weight of inulin, 1.0 part by weight of isomaltooligosaccharide, 1.0 part by weight of arabinogalactan, 0.1 part by weight of dihydroquercetin, 0.1 part by weight of lactobacillus reuteri, and 0.1 part by weight of epigallocatechin gallate.
The technical scheme of the invention is that rare plants are used as raw materials, various natural bioactive substances are extracted by processes of normal-temperature ultrahigh-pressure extraction, molecular vibration membrane concentration, ultralow-temperature freeze-drying, low-temperature convection crushing and the like, and the natural bioactive substances are compounded and processed into the health-care food. The technical scheme of the invention follows the concept of taking food as medicine and taking food as main, and the ideal aims of eliminating helicobacter pylori, reducing the generation of side effects and realizing nutritional function supplement are achieved to the maximum extent.
The technical scheme of the invention utilizes the spicy plants to extract the functional components to eliminate the helicobacter pylori infection source; the cranberry fruit powder, the hericium erinaceus, the bovine colostrum powder and the lactoferrin are added to block the helicobacter pylori Homb protein, the helicobacter pylori Homb protein is wrapped and taken out of a body, and the propagation path is cut off; the nonspecific immune response capability of organisms is improved through the plant polysaccharide, the prebiotics and the dihydroquercetin, and susceptible people are protected, so that the helicobacter pylori is completely eradicated.
The natural composite powder for removing helicobacter pylori in vivo is prepared by extracting various natural bioactive substances from rare plants serving as raw materials through processes of normal-temperature ultrahigh-pressure extraction, molecular vibration membrane concentration, ultralow-temperature freeze drying, low-temperature convection crushing and the like, and compounding the natural bioactive substances with beneficial substances such as prebiotics, prebiotics and the like.
The international world health organization has identified helicobacter pylori as the first cause of gastric cancer. The existing method for removing the helicobacter pylori mostly adopts a quadruple therapy (namely, the combined use of four antibiotics), which not only can cause allergic reactions such as rash and urticaria, gastrointestinal reactions such as gastrectasia, stomachache or dyspepsia and inappetence, but also can cause symptoms of nerve functions such as dizziness, headache, nausea or somnolence, and the like, but also can possibly cause hemorrheolic diseases such as granulocytopenia, and cannot achieve the effects of safely, comprehensively and effectively removing the helicobacter pylori and repairing gastric mucosa. According to statistics, the Hp infection rate of China is about 40-70%, which is higher than that of developed countries, and the detection rate of Hp in stomach disease patients is far higher than that of common people, which is about 80-90%.
The technical scheme of the invention adopts a normal-temperature ultrahigh-pressure extraction technology and a graded vibrating membrane concentration technology to screen rare spicy plants, and functional components in the rare spicy plants are extracted to eliminate helicobacter pylori infection sources; the cranberry fruit powder, the hericium erinaceus, the bovine colostrum powder and the lactoferrin are added to block the helicobacter pylori Homb protein, the helicobacter pylori Homb protein is wrapped and taken out of a body, and the propagation path is cut off; the nonspecific immune response capability of organisms is improved through the plant polysaccharide, the prebiotics and the dihydroquercetin, and susceptible people are protected, so that the helicobacter pylori is completely eradicated.
The invention adopts the vibration membrane separation concentration process to treat the extracting solution, thereby realizing the effects of microfiltration, ultrafiltration and nanofiltration to remove impurities and concentrate, replacing the 'alcohol precipitation and impurity removal' and 'static membrane concentration' used in the processes of removing impurities and concentrating after the conventional hot water extraction, reducing the organic pollution of the environment and avoiding the problem that the extraction efficiency is influenced by the blockage of the static membrane.
Clove, hericium erinaceus, poria cocos, kudzu vine root, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried orange peel, ginger, arabinogalactan, fructo-oligosaccharide, isomaltooligosaccharide, yeast beta-glucan, epigallocatechin gallate, cranberry fruit powder, bovine colostrum powder, lactoferrin, lactobacillus reuteri, dihydroquercetin and other active ingredients, the effect of removing helicobacter pylori is ideal, but as various bioactive substances of the active ingredients belong to heat-sensitive ingredients and cannot be extracted at high temperature, the active ingredients can be effectively extracted by adopting an extraction process of repeatedly extracting for 2-6 times at 580Mpa-620Mpa normal-temperature and ultrahigh-pressure extraction time of 8-40 minutes/time.
The invention adopts the high-low temperature freeze drying and low-temperature convection crushing processes to dry and crush the extracting solution, ensures that the raw materials are processed in the whole process by adopting the low-temperature process, and does not damage the components of bioactive substances.
The technical scheme of the invention can effectively retain bioactive substances in the powder, so that the composite powder can effectively block the helicobacter pylori Homb protein, wrap the helicobacter pylori Homb protein out of a body and cut off a propagation path; the nonspecific immune response capability of organisms is improved through the plant polysaccharide, the prebiotics and the dihydroquercetin, susceptible people are protected, the helicobacter pylori is thoroughly eradicated, the nutritive value and the action function are more obvious, the effects of removing the helicobacter pylori in vivo and repairing gastric mucosa are achieved, and the natural, safe and thorough characteristics are achieved.
The natural helicobacter pylori-removing composite powder and the preparation method thereof are further explained below.
The natural composite powder is prepared by the following steps:
A. preparing raw materials including clove, hericium erinaceus, poria cocos, kudzu root, lotus root starch, glutinous rice flour, cinnamon, fennel, nutmeg, dried orange peel, ginger, arabinogalactan, fructo-oligosaccharide, isomalto-oligosaccharide, yeast beta-glucan, epigallocatechin gallate, cranberry fruit powder, bovine colostrum powder, lactoferrin, lactobacillus reuteri and dihydroquercetin;
B. selecting and cleaning and crushing the same weight parts of dried clove, hericium erinaceus, poria cocos, kudzu vine root, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried orange peel and ginger, adding 18-22 weight parts of water into the crushed traditional Chinese medicine according to the proportion of 0.8-1.2 weight parts of crushed traditional Chinese medicine, putting the mixture into an extraction bottle, putting the extraction bottle into a normal-temperature ultrahigh-pressure extractor, carrying out normal-temperature ultrahigh-pressure extraction at a constant pressure of 580MPa-620MPa for 8-40 minutes/time, taking out the extraction bottle, pouring out the traditional Chinese medicine extracting solution from the extraction bottle, adding 18-22 weight parts of water into the extraction bottle again, putting the extraction bottle into the normal-temperature ultrahigh-pressure extractor after mixing, carrying out normal-temperature ultrahigh-pressure extraction at a constant pressure of 580MPa-620MPa for 8-40 minutes/time, then taking out the extraction bottle, pouring out the Chinese medicinal extractive solution from the extraction bottle, repeating the extraction for 2-6 times, and filtering to obtain Chinese medicinal extractive solution;
C. b, selecting membrane packages with different molecular weights of 20-500nm from the traditional Chinese medicine extracting solution obtained in the step B, and concentrating by adopting a graded vibration membrane for later use;
D. c, spreading 18-22 parts by weight of the traditional Chinese medicine extracting solution obtained in the step C in a freeze-drying chamber at the temperature of-80 ℃ for low-temperature drying;
E. d, collecting the dried substance obtained in the step D, putting the dried substance into a convection crusher, adopting 3000-10000 convection crushing, and filtering a 120-mesh sieve to obtain powder for later use;
F. and E, mixing 1 weight part of fructo-oligosaccharide, 0.8-1.2 weight parts of yeast beta-glucan, 0.8-1.2 weight parts of cranberry fruit powder, 0.8-1.2 weight parts of bovine colostrum powder, 0.8-1.2 weight parts of lactoferrin, 0.8-1.2 weight parts of inulin, 0.8-1.2 weight parts of isomaltooligosaccharide, 0.8-1.2 weight parts of arabinogalactan, 0.08-0.12 weight parts of dihydroquercetin, 0.08-0.12 weight parts of lactobacillus reuteri and 0.08-0.12 weight parts of epigallocatechin gallate to obtain a finished product of the compound powder with the helicobacter pylori naturally removed.
As a further improvement of the invention, in the step B, 19-21 parts by weight of water is added into 0.9-1.1 part by weight of crushed traditional Chinese medicine and mixed and put into an extraction bottle, the extraction bottle is put into a normal temperature and ultrahigh pressure extractor, normal temperature and ultrahigh pressure extraction is carried out at a constant pressure of 590Mpa-610Mpa for 9-11 minutes/time, then the extraction bottle is taken out, the traditional Chinese medicine extracting solution is poured out of the extraction bottle, 19-21 parts by weight of water is added into the extraction bottle again, after mixing, the extraction bottle is put into the normal temperature and ultrahigh pressure extractor, normal temperature and ultrahigh pressure extraction is carried out at a constant pressure of 590-610 Mpa for 9-11 minutes/time, then the extraction bottle is taken out, the traditional Chinese medicine extracting solution is poured out of the extraction bottle, and the traditional Chinese medicine extracting solution is extracted 3-5 times repeatedly in this way, and the obtained traditional Chinese medicine extracting solution is filtered, standby;
in the step C, the traditional Chinese medicine extracting solution obtained in the step B is selected from membrane packages with different molecular weights of 20-100nm, 100-300nm and 450-500nm and is concentrated by adopting a graded vibrating membrane for later use;
d, flatly spreading the 19-21 parts by weight of the traditional Chinese medicine extracting solution obtained in the step C into a freeze-drying chamber at the temperature of-80 ℃ for low-temperature drying;
step E, collecting the dried substance obtained in the step D, putting the dried substance into a convection crusher, performing 4000-9000 convection crushing, and filtering by a 120-mesh sieve to obtain powder for later use;
and step F, mixing 1 weight part of the powder obtained in the step E, 0.9-1.1 weight part of fructo-oligosaccharide, 0.9-1.1 weight part of yeast beta-glucan, 0.9-1.1 weight part of cranberry fruit powder, 0.9-1.1 weight part of bovine colostrum powder, 0.9-1.1 weight part of lactoferrin, 0.9-1.1 weight part of inulin, 0.9-1.1 weight part of isomaltooligosaccharide, 0.9-1.1 weight part of arabinogalactan, 0.09-0.11 weight part of dihydroquercetin, 0.09-0.11 weight part of lactobacillus reuteri and 0.09-0.11 weight part of epigallocatechin gallate to obtain a finished product of the natural helicobacter pylori-removed composite powder.
As a further improvement of the invention, in the step B, 20 parts by weight of water is added to 1 part by weight of the crushed traditional Chinese medicines, the mixture is placed in an extraction bottle, the extraction bottle is placed in a normal-temperature ultrahigh-pressure extractor, normal-temperature ultrahigh-pressure extraction is carried out at a constant pressure of 600Mpa, the extraction time of normal-temperature ultrahigh pressure is 10 minutes/time, then the extraction bottle is taken out, the traditional Chinese medicine extracting solution is poured out of the extraction bottle, then 20 parts by weight of water is added to the extraction bottle again, the extraction bottle is placed in the normal-temperature ultrahigh-pressure extractor after mixing, normal-temperature ultrahigh-pressure extraction is carried out at a constant pressure of 600Mpa, the extraction time of normal-temperature ultrahigh pressure is 10 minutes/time, then the extraction bottle is taken out, the traditional Chinese medicine extracting solution is poured out of the extraction bottle, and the traditional Chinese medicine extracting solution is repeatedly extracted for 3-4 times and filtered for later use;
in the step C, membrane packages with different molecular weights of 80nm, 200nm and 450nm are selected from the traditional Chinese medicine extracting solution obtained in the step B, and are concentrated by adopting a graded vibration membrane for later use;
step D, spreading 20 parts by weight of the traditional Chinese medicine extracting solution obtained in the step C into a freeze-drying chamber at the temperature of minus 80 ℃ for low-temperature drying;
d, collecting the dried substances obtained in the step D, putting the dried substances into a convection crusher, performing 6000-turn convection crushing, and filtering a 120-mesh sieve to obtain powder for later use;
and step F, mixing the powder obtained in the step E, 1.0 weight part of fructo-oligosaccharide, 1.0 weight part of yeast beta-glucan, 1.0 weight part of cranberry fruit powder, 1.0 weight part of bovine colostrum powder, 1.0 weight part of lactoferrin, 1.0 weight part of inulin, 1.0 weight part of isomaltooligosaccharide, 1.0 weight part of arabinogalactan, 0.1 weight part of dihydroquercetin, 0.1 weight part of lactobacillus reuteri and 0.1 weight part of epigallocatechin gallate to obtain a finished product of the natural helicobacter pylori-removed composite powder.
The functional test of the natural helicobacter pylori removing composite powder selects SPF-level SD rats (with the weight of 140-. After animal quarantine is qualified, the animals are randomly divided into 6 groups of blank control group, model control group, positive control group, formula group low and high dose group, 10 groups/group according to body weight. The experiment was carried out in 2 batches of 5 each, 1 batch, 2 batches separated by 1 day. Wherein the low and high dosages of the formula are respectively 10 and 30 times of the human recommended amount of the natural composite powder.
And (3) intragastrically administering a test sample with a corresponding formula according to 10mL/kg body weight every day, intragastrically administering sucralfate oral suspension to a positive control group by the same method, and intragastrically administering a solvent to a blank control group and a model control group by the same method for 1 time/d, and continuously administering for 30 days. After the last dose, all animals were strictly fasted for 24 h. Except for a blank control group, the other animals in each group are subjected to intragastric administration of absolute ethyl alcohol, the intragastric volume is 1.0 mL/animal, the animals are euthanized after being subjected to intragastric administration of ethanol for 1h, cardia is ligated, 8mL of 10% neutral formaldehyde solution is injected from a pylorus of the stomach, suture ligation is performed, the filled stomach body is cut, the stomach body is soaked in 5% formaldehyde solution, fixation is performed for 20min, then the appetizing wall is cut along the lesser curvature of the stomach, the stomach mucosa is unfolded after contents are cleaned away from a bleeding zone and the content is cut along the greater curvature of the stomach, and corresponding index detection is performed. After the gastric mucosa was developed, the length and width of the bleeding point or band were visually measured with a vernier caliper, and the score was calculated as shown in table 1 to obtain the total score, and the incidence of injury (%), the index of injury score and the inhibition of injury were calculated according to the following formulas.
The incidence of injury (%) - (number of rats with bleeding or ulceration in a group/number of rats in the group X100%
Injury score index-group injury score sum/number of animals in group
The injury inhibition rate (%) is (model control injury integral-test substance group injury integral)/model control injury integral x 100%
All data are expressed as (XS), statistical analysis is performed using SPSS21.0 software; analyzing the body weight by repeated measurement variance; visual observation scores and histopathological scores were analyzed by variance: performing T test on the blank control group and the model control group, and performing variance analysis on each administration group separately with the model control group and the positive control group; the incidence of damage was examined using chi-square. The test level α is 0.05.
Compared with a model control group, the damage incidence rate and the damage integral index of the positive control group and the formula group are reduced, wherein the damage inhibition rates of the positive control group and the formula group in the low-dosage and high-dosage groups are respectively 46.2%, 20.7% and 62.5%, which shows that the formula group can reduce the incidence rate and the damage integral index of gastric mucosa damage to a certain extent, and the result of increasing the damage inhibition rate is shown in table 1. As can be seen from Table 2, the gastric mucosa of the model group rats had severe congestion, hemorrhage and epithelial cell necrosis, and the histopathological score of the gastric mucosa injury was increased. The congestion, bleeding and epithelial cell necrosis of the gastric mucosa of the rat in the high-dose group of the formula are all reduced, and the damage score is all obviously reduced. The formula group has different degrees of protection effects on the gastric mucosa, so that the acute injury of the gastric mucosa is relieved.
TABLE 1 results of acute injury visual observation and scoring
Group of | n | Dose/(g/kg) | Visual evaluation of scores | Incidence of damage/%) | Integral index of damage | Wound inhibition rate/%) |
Blank control group | 10 | —— | 0 ** | 0 ** | 0 | 100 |
Model control group | 10 | —— | 35.3±8.4 | 100 | 35.3 | / |
Positive control group | 10 | 6.7mL/kg | 19.0±11.2** | 90 | 19 | 46.2 |
Formulation ofGroup Low dose | 10 | 0.48 | 41.5±16.0 | 80 | 28.5 | 20.7 |
Formula group high dose | 10 | 1.46 | 21.6±18.4* | 90 | 16 | 62.5 |
Note: p < 0.05, P < 0.01 compared to model control.
TABLE 2 histopathological examination of gastric mucosa
Note: p < 0.05, P < 0.01 compared to model control.
Ulcer formation is caused by various factors, such as infection with HP, hypersecretion of gastric acid, damage to gastric mucosa, etc., and among them, infection with HP is the most important cause of gastric ulcer. Its main mechanism is: inflammation following HP infection causes damage to the gastric mucosa, which is not effective against the low acidity in the stomach causing ulcers. The results of pharmacodynamic experiments in vivo of the natural helicobacter pylori-removing composite powder show that the composite powder has the function of reducing ulcer indexes for various experimental animal gastric ulcer models, and the inhibition rate shows dose effect correlation. The composition has the effects of reducing the activity of urease in gastric tissues and the content of NO and increasing the content of PGE in HP gastric ulcer mice.
Hericium erinaceus is not only a precious edible product but also an important medicinal fungus in China. Hericium erinaceus is one of eight Chinese "mountain delicacies", since ancient times, there is a saying that "mountain delicacies Hericium erinaceus, seafood bird's nest", and bear's paw, sea cucumber and shark's wing are listed as four famous vegetables, tender meat is delicious, delicious and tasty, nutritious, and the color, fragrance and taste are superior. In addition, the hericium erinaceus is also a traditional Chinese precious traditional Chinese medicine and has the functions of nourishing, building body, promoting digestion and benefiting five internal organs. Modern researches show that the traditional Chinese medicine composition contains active ingredients such as polypeptide, polysaccharide, fat, protein and the like, and has certain curative effects on digestive tract tumors, gastric ulcer, duodenal ulcer, gastritis, abdominal distension and the like.
Inulin is contained in the protoplast of a cell in a colloidal form, is easily dissolved in hot water unlike starch, is precipitated from water by adding ethanol, and does not react with iodine. Inulin is also very easily hydrolyzed to fructose under dilute acid, which is characteristic of all fructans. Can also be hydrolyzed into fructose by inulase. Enzymes that break down inulin are lacking in both humans and animals. Inulin is a natural water-soluble dietary fiber, hardly hydrolyzed and digested by gastric acid, and is utilized only in the colon by beneficial microorganisms, thereby improving the intestinal environment. It has been found that the degree of proliferation of bifidobacteria depends on the number of primary bifidobacteria in the large intestine of humans, and that the effect of proliferation is significant when inulin is used when the number of primary bifidobacteria is reduced, and not significant when inulin is used when the number of primary bifidobacteria is increased. Secondly, after the inulin is ingested, the gastrointestinal peristalsis can be enhanced, the gastrointestinal function can be improved, the digestion and the appetite can be increased, and the organism immunity can be improved.
The arabinogalactan is neutral polysaccharide composed of arabinose and galactose. The sugar is contained in the xylem of conifers in large amounts, up to 25% in particular in larch, and can be extracted from wood flour with water. The content ratio of L-arabinose to D-galactose is generally 1: 5-6. Is a structure with many branches, and beta-1, 3-bond arabinose side chains are connected in beta-1, 3-bond or beta-1, 6-bond galactose chains. The dietary fiber not only has strong function of activating immune function, but also can directionally deliver nutrient substances, and is a good dietary fiber.
When the traditional medicine is used for treating the gastrointestinal diseases, not only are harmful bacteria in intestines and stomachs killed, but also beneficial bacteria are damaged, and the balance of the bacteria in the intestines and the stomachs is directly destroyed, which is the root cause of repeated attack of duodenal ulcer. If the antibiotic is taken for a long time, the human body can generate extremely stubborn 014 drug-resistant bacteria which harm other organs in the body. The invention aims to provide the hericium erinaceus and inulin composite beverage which is fine in taste and rich in nutrition, so that the problem is solved fundamentally, harmful bacteria in intestines and stomach are effectively killed, and beneficial bacteria are not damaged; eliminates harmful bacteria such as helicobacter pylori and escherichia coli from the source, and effectively prevents the deterioration of the duodenal ulcer.
The invention adopts the vibration membrane separation concentration process to treat the extracting solution, thereby realizing the effects of microfiltration, ultrafiltration and nanofiltration to remove impurities and concentrate, replacing the 'alcohol precipitation and impurity removal' and 'static membrane concentration' used in the processes of removing impurities and concentrating after the conventional hot water extraction, reducing the organic pollution of the environment and avoiding the problem that the extraction efficiency is influenced by the blockage of the static membrane.
The hericium erinaceus contains active ingredients such as polypeptide, polysaccharide, fat and protein, and the like, has ideal effect on repairing gastric mucosa, but the roots of the dried products need to be removed before processing and extraction because the bitter glycoside ingredients are generated at the roots of the dried products, so the taste is influenced, the extraction time is 8-40 minutes/time by adopting a 580Mpa-620Mpa normal-temperature ultrahigh-pressure extraction technology, the extraction process is repeated for 2-6 times, the bioactive ingredients can be effectively extracted, and simultaneously the bitter taste is greatly reduced.
The invention adopts an extraction process of extracting under the constant pressure of 580Mpa-620Mpa in a normal temperature and ultrahigh pressure extractor for 8-40 minutes/time and repeatedly extracting for 2-6 times, so that not only can bioactive substances in the materials be effectively extracted, but also aromatic substances can be effectively retained in an extracting solution.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Claims (10)
1. A preparation method of natural composite powder for removing helicobacter pylori in vivo is characterized by comprising the following steps:
A. preparing clove, hericium erinaceus, poria cocos, kudzu vine root, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried orange peel, ginger, arabinogalactan, fructooligosaccharide, isomaltooligosaccharide, yeast beta-glucan, epigallocatechin gallate, cranberry fruit powder, bovine colostrum powder, lactoferrin, lactobacillus reuteri and dihydroquercetin;
B. preparing the mixed traditional Chinese medicine extract of clove, hericium erinaceus, poria cocos, radix puerariae, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried orange peel and ginger in equal parts by weight;
C. b, concentrating the traditional Chinese medicine extracting solution obtained in the step B;
D. c, spreading the traditional Chinese medicine extracting solution obtained in the step C into a freeze-drying chamber at the temperature of-80 ℃ for low-temperature drying;
E. d, crushing the dried substance obtained in the step D, and filtering the crushed substance through a 120-mesh sieve to obtain powder;
F. and E, mixing 1 part by weight of fructo-oligosaccharide, 0.8-1.2 parts by weight of yeast beta-glucan, 0.8-1.2 parts by weight of cranberry fruit powder, 0.8-1.2 parts by weight of bovine colostrum powder, 0.8-1.2 parts by weight of lactoferrin, 0.8-1.2 parts by weight of inulin, 0.8-1.2 parts by weight of isomaltooligosaccharide, 0.8-1.2 parts by weight of arabinogalactan, 0.08-0.12 parts by weight of dihydroquercetin, 0.08-0.12 parts by weight of lactobacillus reuteri and 0.08-0.12 parts by weight of epigallocatechin gallate to obtain the natural composite powder for removing helicobacter pylori in vivo.
2. The method for preparing natural composite powder for removing helicobacter pylori in vivo according to claim 1, wherein the step B comprises: selecting equal parts by weight of moldy and rotten-free, worm-eaten-free and dried clove, hericium erinaceus, poria cocos, radix puerariae, lotus root starch, glutinous rice flour, cassia bark, fennel, nutmeg, dried tangerine peel and dried ginger, cleaning and crushing, mixing crushed mixed materials 0.8-1.2 parts by weight with 18-22 parts by weight of water, putting the mixed materials into an extraction bottle, putting the extraction bottle into a normal-temperature ultrahigh-pressure extractor, carrying out normal-temperature ultrahigh-pressure extraction at a constant pressure of 580MPa-620MPa for 8-40 min/time, pouring out traditional Chinese medicine extracting solution from the extraction bottle, adding 18-22 parts by weight of water into the extraction bottle again, mixing, putting the extraction bottle into the normal-temperature ultrahigh-pressure extractor, carrying out normal-temperature ultrahigh-pressure extraction at a constant pressure of 580MPa-620MPa for 8-40 min/time, taking out the extraction bottle, pouring out the traditional Chinese medicine extracting solution from the extraction bottle, repeating the extraction for 2-6 times, and filtering to obtain Chinese medicinal extractive solution.
3. The method for preparing natural composite powder for removing helicobacter pylori in vivo according to claim 2, wherein the step C comprises: and D, selecting membrane packages with different molecular weights of 20-500nm from the traditional Chinese medicine extract obtained in the step B, and concentrating by using a graded vibration membrane.
4. The method for preparing natural composite powder for removing helicobacter pylori from the body as claimed in claim 3, wherein step C is to select the membrane packages with different molecular weights of 20-100nm, 100-300nm and 450-500nm from the Chinese medicine extract obtained in step B and concentrate the Chinese medicine extract by using a graded vibrating membrane.
5. The method for preparing a natural composite powder for removing helicobacter pylori according to claim 4, wherein the step D comprises spreading the 19-21 parts by weight of the Chinese medicinal extract obtained in the step C in a freeze-drying chamber at-80 ℃ and drying at low temperature.
6. The method as claimed in claim 5, wherein the step E comprises collecting the dried powder obtained in step D, pulverizing the collected powder in a convection pulverizer, and sieving the pulverized powder with a 120-mesh sieve after 4000-9000 convection pulverization.
7. The method according to claim 6, wherein the step F comprises mixing the powder obtained in step E with 1 part by weight of fructo-oligosaccharide, 0.9-1.1 parts by weight of yeast β -glucan, 0.9-1.1 parts by weight of cranberry fruit powder, 0.9-1.1 parts by weight of bovine colostrum powder, 0.9-1.1 parts by weight of lactoferrin, 0.9-1.1 parts by weight of inulin, 0.9-1.1 parts by weight of isomaltooligosaccharide, 0.9-1.1 parts by weight of arabinogalactan, 0.09-0.11 parts by weight of dihydroquercetin, 0.09-0.11 parts by weight of Lactobacillus reuteri, and 0.09-0.11 parts by weight of epigallocatechin gallate to obtain the natural helicobacter pylori-containing composite powder.
8. A natural composite powder for removing helicobacter pylori in vivo is characterized by comprising: 0.8-1.2 parts of fructo-oligosaccharide, 0.8-1.2 parts of yeast beta-glucan, 0.8-1.2 parts of cranberry fruit powder, 0.8-1.2 parts of bovine colostrum powder, 0.8-1.2 parts of lactoferrin, 0.8-1.2 parts of inulin, 0.8-1.2 parts of isomaltooligosaccharide, 0.8-1.2 parts of arabinogalactan, 0.08-0.12 parts of dihydroquercetin, 0.08-0.12 parts of lactobacillus reuteri, 0.08-0.12 parts of epigallocatechin gallate and 1 part of mixed traditional Chinese medicine by weight, wherein the mixed traditional Chinese medicine comprises clove, hericium erinaceus, poria cocos, kudzu root, lotus root starch, sticky rice powder, common fennel, nutmeg, dried orange peel and ginger in equal parts by weight.
9. The natural composite powder for removing helicobacter pylori bacteria in vivo according to claim 8, comprising: 0.9-1.1 weight parts of fructo-oligosaccharide, 0.9-1.1 weight parts of yeast beta-glucan, 0.9-1.1 weight parts of cranberry fruit powder, 0.9-1.1 weight parts of bovine colostrum powder, 0.9-1.1 weight parts of lactoferrin, 0.9-1.1 weight parts of inulin, 0.9-1.1 weight parts of isomaltooligosaccharide, 0.9-1.1 weight parts of arabinogalactan, 0.09-0.11 weight parts of dihydroquercetin, 0.09-0.11 weight parts of lactobacillus reuteri, 0.09-0.11 weight parts of epigallocatechin gallate and 1 weight part of mixed traditional Chinese medicine, wherein the mixed traditional Chinese medicine comprises clove extract, hericium erinaceum extract, poria cocos extract, kudzu root extract, lotus root powder extract, glutinous rice flour extract, cinnamon extract, fennel extract, myristica nutmeg extract, dried orange peel extract and the same weight parts of mixed traditional Chinese medicine, Ginger extract.
10. The natural composite powder for removing helicobacter pylori bacteria in vivo according to claim 9, comprising: 1.0 part by weight of fructo-oligosaccharide, 1.0 part by weight of yeast beta-glucan, 1.0 part by weight of cranberry fruit powder, 1.0 part by weight of bovine colostrum powder, 1.0 part by weight of lactoferrin, 1.0 part by weight of inulin, 1.0 part by weight of isomaltooligosaccharide, 1.0 part by weight of arabinogalactan, 0.1 part by weight of dihydroquercetin, 0.1 part by weight of lactobacillus reuteri, and 0.1 part by weight of epigallocatechin gallate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210465121.8A CN114938856A (en) | 2022-04-29 | 2022-04-29 | Natural composite powder for removing helicobacter pylori in vivo and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210465121.8A CN114938856A (en) | 2022-04-29 | 2022-04-29 | Natural composite powder for removing helicobacter pylori in vivo and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114938856A true CN114938856A (en) | 2022-08-26 |
Family
ID=82906288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210465121.8A Withdrawn CN114938856A (en) | 2022-04-29 | 2022-04-29 | Natural composite powder for removing helicobacter pylori in vivo and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114938856A (en) |
-
2022
- 2022-04-29 CN CN202210465121.8A patent/CN114938856A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100566723C (en) | Carbohydrase inhibitor and application thereof derived from the acorn-cup plant | |
CN109106944A (en) | It is a kind of prevent and treat osteoarthritis composition and its application | |
JP2006045212A (en) | Oral composition containing specific quinic acid derivative | |
JP2002275076A (en) | Inhibitor of elevation of glycemia and healthy food | |
KR100597235B1 (en) | Composition comprising Schizandrae Fructus extract as an effective component for preventing and treating arthritis | |
CN106722931A (en) | A kind of coordinating intestines and stomach and composition of improvement constipation and preparation method thereof | |
JP4352029B2 (en) | healthy food | |
KR101904702B1 (en) | Composition for immune enhancement and method the same | |
JP2006045213A (en) | Oral composition containing specific quinic acid derivative | |
KR102036962B1 (en) | Composition for Anti-Diabetes Using an Extract of Ecklonia cava etc. | |
CN112655802A (en) | Calcium gel candy and preparation process thereof | |
KR101930433B1 (en) | manufacturing method of sweet jelly containing mealworm and sweet jelly containing mealworm made by the same | |
CN109589400B (en) | Composition with neuroprotective effect | |
CN104187955B (en) | A kind of Corn Pollen Healthy Beverage | |
JP2003339353A (en) | Food for beauty | |
CN111328948A (en) | Ginger paste and preparation method thereof | |
CN114938856A (en) | Natural composite powder for removing helicobacter pylori in vivo and preparation method thereof | |
US9737583B2 (en) | Composition for prevention or treatment of acute renal failure including herbal extract or fraction thereof as active ingredient | |
KR102411634B1 (en) | Health functional food composition for improvement of bowel function and relief of contipation comprising psyllium husk and complex extract, and manufacturing method thereof | |
JP2005237291A (en) | Health food | |
JP2005278654A (en) | Arthritis-improving food | |
CN114532528A (en) | Red-pulp apple and cherry plum composition and application thereof in antithrombotic aspect | |
KR20220066771A (en) | Method for producing powder containing sweet persimmon and method for producing powdered food using the same | |
CN113995069A (en) | Hericium erinaceus and inulin composite beverage and preparation method thereof | |
JP2005237290A (en) | Health food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20220826 |